🇳🇱 Netherlands Country × Condition
cancer Clinical Trials in Netherlands
Active clinical trials for cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 2, Phase 3, Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇳🇱 Netherlands
Active Trials in Netherlands (4)
NCT06672887 Phase 2, Phase 3
Recruiting
Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)
Enrollment
140 pts
Country
🇳🇱 Netherlands
Academisch Medisch Centrum - Univer...
View Trial → NCT05958121 Phase 1, Phase 2
Recruiting
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
Enrollment
400 pts
Country
🇳🇱 Netherlands
Immatics Biotechnologies GmbH
View Trial → NCT06680778
Recruiting
Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch
Enrollment
175 pts
Country
🇳🇱 Netherlands
Erasmus Medical Center
View Trial → NCT04682470
Recruiting
The Prospective Observational COMPRAYA Cohort Study
Enrollment
4,000 pts
Country
🇳🇱 Netherlands
The Netherlands Cancer Institute
View Trial → Frequently Asked Questions
How many cancer clinical trials are active in Netherlands?
There are currently 4 active clinical trials for cancer with sites in Netherlands, of which 4 are actively recruiting patients.
How can I join a cancer clinical trial in Netherlands?
To join a cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cancer trials in Netherlands?
Active cancer trials in Netherlands span Phase 2, Phase 3, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology